Surgical reduction in chest wall disease to prolong survival in breast cancer patients: a retrospective study
Author(s) -
Anjie Zhu,
Zehui Yun,
Miaoning You,
Xiaoran Liu,
Xu Liang,
Ying Yan,
Bin Shao,
Hanfang Jiang,
Lijun Di,
Guohong Song,
Huiping Li
Publication year - 2022
Publication title -
gland surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.643
H-Index - 22
eISSN - 2227-8575
pISSN - 2227-684X
DOI - 10.21037/gs-22-246
Subject(s) - medicine , thoracic wall , breast cancer , retrospective cohort study , surgery , pathological , stage (stratigraphy) , disease , confidence interval , cancer , statistical significance , paleontology , biology
Patients with breast cancer (BC) may develop locoregional recurrence alone or with distant metastases. Results of previous studies discussing the benefit of local surgery among patients with chest wall disease were controversial. Whether surgical reduction for chest wall disease could influence survival outcome is still a question. The objective of this study was to compare overall survival (OS) in patients with recurrence involving the chest wall who did or did not undergo surgical reduction after previous treatment of the primary BC to explore the role of surgical reduction.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom